Regentis Biomaterials Ltd. (RGNT) Stock Analysis
A live, multi-source view of Regentis Biomaterials Ltd. (RGNT): real-time price, technical indicators, Wall Street analyst consensus, recent news sentiment and social buzz — aggregated into one place so you can size up the stock at a glance.
About Regentis Biomaterials Ltd.
Regentis Biomaterials Ltd., a regenerative medicine company, develops and commercializes tissue repair solutions in the United States. It offers Gelrin, a platform based on hydrogel matrix of polyethylene glycol diacrylate and denatured fibrinogen for the treatment and regeneration of damaged or diseased tissue; and GelrinC, a cell-free and off-the-shelf hydrogel, which is in Phase II clinical trial for the treatment of cartilage injuries in the knee. The company was incorporated in 2004 and is based in Herzliya, Israel.
Sector: Healthcare · Industry: Medical Instruments & Supplies · Israel · regentis.co.il
Key statistics · as of 2026-09-06
As of 2026-09-06, Regentis Biomaterials Ltd. (RGNT) had a market capitalization of $13.8M; the shares traded in a 52-week range of $1.23 – $15.50 (-73.7% over the year).
- Market cap
- $13.8M
- Enterprise value
- $4.0M
- Price / book
- 2.15
- EPS (trailing)
- $-24.16
- Payout ratio
- 0.0%
- 52-week range
- $1.23 – $15.50
- 52-week change
- -73.7%
- Average volume
- 5.3M
- Shares outstanding
- 7.0M
- Short % of float
- 0.16%
- Profit margin
- 0.0%
Fundamental figures are recorded once every few days, dated above; they are not live and can differ from the interactive tiles.
Last universe scan · 2026-09-11
In RapidTradeView’s 2026-09-11 scan of the US universe, Regentis Biomaterials Ltd. (RGNT) last closed at $1.96 (the last completed close before that scan).
Technicals at the scan: RSI 44 (neutral territory), price -3.9% versus its 20-day average, 20-day versus 50-day average spread -11.7%, MACD histogram 0.02.
Sentiment inputs: StockTwits 100% bullish.
Scan values are recorded once per trading day and are not live quotes; the interactive tiles above update in real time.
Smart Money · last 90 days
RapidTradeView has recorded no Congress or insider filing for RGNT in the last 90 days. Coverage of House, Senate and SEC Form 4 filings began in July 2026, and insider sells are tracked for universe tickers only, so this is our record, not a guarantee that nothing was filed. Who is trading what
RapidTradeView pick record
RGNT has not appeared in the daily picks yet. Full scoreboard
What this page covers
RapidTradeView pulls Regentis Biomaterials Ltd. (RGNT) data from multiple independent sources and combines it into a single dashboard. Below the summary you’ll find live, interactive tiles for each of the following:
- Price & chart — real-time quote with pre/post-market moves and a line or candlestick chart.
- Technical indicators — RSI, MACD, moving averages, Bollinger Bands, volume and support/resistance, distilled into one overall signal.
- Analyst consensus — the buy/hold/sell breakdown and price targets published by Wall Street analysts.
- News sentiment — recent headlines, each scored for tone so the prevailing narrative is obvious.
- Earnings — current EPS, year-over-year change and the next scheduled earnings date.
- Social buzz — Reddit mention volume and StockTwits sentiment for the retail-trader angle.
How to read the signals
No single indicator tells the whole story. A bullish technical reading paired with a cautious analyst consensus, or strong social buzz against weak earnings, is exactly the kind of tension this view is built to surface. RapidTradeView’s signals are generated by deterministic, statistical models — they describe what the data is doing, they are not personalised recommendations to buy or sell RGNT.
Disclaimer: RapidTradeView is an educational sentiment-aggregation tool, not a licensed financial adviser, broker, or dealer. Nothing here is financial, investment, tax, or legal advice. Markets are risky and you can lose money. Always do your own research and consult a qualified professional before making any investment decision.